Phase I study of roniciclib (BAY1000394), an oral CDK inhibitor in Japanese patients with advanced solid tumors

被引：0
|
作者：
Seto, Takashi [1 ]
Nosaki, Kaname [1 ]
Shinoda, Gen [2 ]
Hashizume, Kensei [2 ]
Yamaguchi, Iku [2 ]
Tsuburaya, Jun [2 ]
Nogai, Hendrik [3 ]
Shitara, Kohei [4 ]
Yoh, Kiyotaka [4 ]
机构：
[1] Kyushu Natl Canc Ctr, Fukuoka, Japan
[2] Bayer Yakuhin Ltd, Osaka, Japan
[3] Bayer Pharma AG, Berlin, Germany
[4] Natl Canc Ctr Hosp East, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3-5-3
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase I study of oral administration of the histone deacetylase (HDAC) inhibitor belinostat in patients (pts) with advanced solid tumors
    Kelly, W.
    Petrylak, D.
    Blumenschein, G.
    Lassen, U.
    Jensen, P. Buhl
    DeBono, J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 127 - 127
  • [42] Phase I study of the safety and pharmacokinetics of epitinib, an oral EGFR tyrosine kinase inhibitor, in patients with advanced solid tumors
    Zhou, Qing
    Wu, Yi Long
    Yu, Xiyong
    Yang, Jinji
    Wen, Limin
    Sai, Yang
    Mu, Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] A phase I study of oral darinaparsin in patients (pts) with advanced solid tumors (AST).
    Camacho, Luis H.
    Senzer, Neil N.
    Harb, Wael A.
    Barrett, John A.
    Korth, Christopher Charles
    Astl, Dorothea
    Jac, Jaroslaw
    Youssoufian, Hagop
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors
    Elisabeth I. Heath
    Seamus O'Reilly
    Rachel Humphrey
    Pavur Sundaresan
    Ross C. Donehower
    Susan Sartorius
    John M. Kennedy
    Deborah K. Armstrong
    Michael A. Carducci
    Mel J. Sorensen
    Karen Kumor
    Sean Kennedy
    Louise B. Grochow
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 269 - 274
  • [45] Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors
    Heath, EI
    O'Reilly, S
    Humphrey, R
    Sundaresan, P
    Donehower, RC
    Sartorius, S
    Kennedy, MJ
    Armstrong, DK
    Carducci, MA
    Sorensen, JM
    Kumor, K
    Kennedy, S
    Grochow, LB
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (04) : 269 - 274
  • [46] Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
    A. Stathis
    D. Hess
    R. von Moos
    K. Homicsko
    G. Griguolo
    M. Joerger
    M. Mark
    C. J. Ackermann
    S. Allegrini
    C. V. Catapano
    A. Xyrafas
    M. Enoiu
    S. Berardi
    P. Gargiulo
    C. Sessa
    Investigational New Drugs, 2017, 35 : 766 - 772
  • [47] Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
    Stathis, A.
    Hess, D.
    von Moos, R.
    Homicsko, K.
    Griguolo, G.
    Joerger, M.
    Mark, M.
    Ackermann, C. J.
    Allegrini, S.
    Catapano, C. V.
    Xyrafas, A.
    Enoiu, M.
    Berardi, S.
    Gargiulo, P.
    Sessa, C.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 766 - 772
  • [48] Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamada, Yasuhide
    Yamamoto, Noboru
    Sunami, Kuniko
    Utsumi, Hirofumi
    Asou, Hiroya
    Takahash, Osamu, I
    Ogasawara, Ken
    Gueorguieva, Ivelina
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1143 - 1152
  • [49] A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors
    Toshihiko Doi
    Nozomu Fuse
    Takayuki Yoshino
    Takashi Kojima
    Hideaki Bando
    Hideaki Miyamoto
    Masato Kaneko
    Motonobu Osada
    Atsushi Ohtsu
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 89 - 98
  • [50] Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors
    Yutaka Fujiwara
    Hiroshi Nokihara
    Yasuhide Yamada
    Noboru Yamamoto
    Kuniko Sunami
    Hirofumi Utsumi
    Hiroya Asou
    Osamu TakahashI
    Ken Ogasawara
    Ivelina Gueorguieva
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1143 - 1152
12345